Daily non-political popular news in brief.
Other highlights in the Jan. 8 JNCI
01-08-2008 · EurekAlert!Also in the Jan. 8 JNCI are an association between statin use and reduced cancer risk, a potential colon cancer drug target, a mouse model for studying kidney cancer, and a review of how tumor viruses regulate telomeres.
Read more »
Keywords: highlights, jan, jnci, highlight
« Previous | Next »
Similar news on "Other highlights in the Jan. 8 JNCI":
- Other highlights in the Jan. 29 JNCI
01-29-2008 · EurekAlert!
Also in the Jan. 29 JNCI are a protein associated with breast cancer prognosis, a study that refutes the idea that personality traits are linked to cancer, a study confirming the accuracy of pathology reports used in breast cancer trials, and an article demonstrating sorafinib’s potential for treating some leukemias.
Similar news · Read more »
- Other highlights in the Jan. 17 JNCI
01-16-2007 · EurekAlert!
Also in the Jan. 17 JNCI are studies about calcium supplements protecting against colorectal adenomas; antioxidents not stopping gastric cancer; allergy's relationship to non-Hodgkin lymphoma; the association between gum disease and pancreatic cancer, and a new biomarker for breast cancer recurrence.
Similar news · Read more »
- Other highlights in the February 21 JNCI
02-20-2007 · EurekAlert!
Also in the February 21 JNCI are a new screening method for those at risk for a hereditary colorectal cancer, a mouse study of low-dose bisphosphonates' antitumor effects, and research on a protein that is active in metastasis suppression.
Similar news · Read more »
- Other highlights in the Aug. 7 JNCI
08-07-2007 · EurekAlert!
Also in the Aug. 7 JNCI are a study showing vitamins and minerals do not improve liver cancer survival, another study on testicular cancer survivors' survival rates for second cancers, a gene expression pattern that predicts lung cancer prognosis and epigenetic changes in Wilms tumor.
Similar news · Read more »
- AGU journal highlights -- Jan. 28, 2008
01-28-2008 · EurekAlert!
Doubling of snow in western Antarctic Peninsula, Good news for larch trees: More wildfires in boreal forests as climate warms, Expansion and contraction of Mars' exosphere with solar cycle, Cyclonic and anticyclonic motion in upper ocean, Sea-surface stratification from global warming shifts phytoplankton habitat, Melting Canadian ice caps.
Similar news · Read more »
- Other highlights in the April 4 JNCI
04-03-2007 · EurekAlert!
Also in the April 4 JNCI are a study on the risk of noncancer death among testicular cancer survivors, a report that celecoxib does not prevent cancer in Barrett's esophagus patients, and a link between bladder cancer and androgens in mice.
Similar news · Read more »
- Other highlights from the June 6 JNCI
06-05-2007 · EurekAlert!
Also in the June 6 JNCI is an association between aspirin use and decreased risk of cancer, a protein that suppresses tumor growth and cell migration, the incidence of a rare cancer in Denmark, and a protein that is not associated with inflammation, but not breast cancer.
Similar news · Read more »
- Media highlights in the January issues of Biophysical Journal
01-29-2008 · EurekAlert!
The Jan. 1 and 15 issues of Biophysical Journal, published by the Biophysical Society, is now available online. Topics of interest include ciliates, force, spasmoneme, H2A/H2B, nucleosome, AFM, aquaporin, elasticity and epithelial cells.
Similar news · Read more »
- Other highlights in the November 1 JNCI
10-31-2006 · EurekAlert!
Other highlights in the November 1 issue of JNCI include a review of statins and fibrates for action against melanoma, a study of a virus that kills brain tumors in mice, an antibody that decreases ovarian cancer growth in mice and a study that describes the use of the immunohistochemical assay in predicting clinical trial results for breast cancer patients.
Similar news · Read more »
- Other highlights in the May 2 JNCI
05-01-2007 · EurekAlert!
Also in the May 2 JNCI is a follow-up to the Italian Randomized Tamoxifen Trial, a study on treating breast cancer patients with three HER inhibitor drugs, an increase in survival rates for indolent lymphoma patients using a chemotherapy-rituximab combination, and new lung cancer risk prediction models.
Similar news · Read more »
